gms | German Medical Science

48th Meeting of the Particle Therapy Co-Operative Group

Particle Therapy Co-Operative Group (PTCOG)

28.09. - 03.10.2009, Heidelberg

NRoCK, North European Radiooncological Center Kiel

Meeting Abstract

Search Medline for

  • R. Kampf - NRoCK GmbH i. Gr., Kiel

PTCOG 48. Meeting of the Particle Therapy Co-Operative Group. Heidelberg, 28.09.-03.10.2009. Düsseldorf: German Medical Science GMS Publishing House; 2009. Doc09ptcog103

doi: 10.3205/09ptcog103, urn:nbn:de:0183-09ptcog1036

Published: September 24, 2009

© 2009 Kampf.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Summary of paper: As a center of competence for malignant tumors at the Medical University Center Schleswig-Holstein (UK S-H), NRoCK will offer new treatments for cancer therapy beginning in 2012. After a two year preparation phase, actual construction of the building began in July 2008.

NRoCK will be among the most innovative centers worldwide for cancer treatments with UK S-H offering the entire spectrum of all modern radiation techniques, as well as chemotherapy and full imaging diagnostics under one roof. This ensures an optimal clinical process from initial diagnosis to therapy and after-care. For particle therapy, an especially tissue-sparing and precise form of treatment will be available.

In close cooperation with partner institutions from Northern Germany and the Baltic, patients will be receiving specialized therapy sparing to the patient. At the same time, experts at the NRoCK will continue to drive research in the area of particle therapy and train expert personnel.

The decision in Kiel calls for building a combined system that allows the use of other particle types in addition to protons. This provides the prerequisites for ongoing scientific research focusing on efficient tumor treatment with particles.

In view of expenditures amounting to 250 million Euros, NRoCK is one of the largest projects within the German healthcare system which will be realized as a public-private partnership. The project partners are UK S-H and a consortium of Siemens AG, Bilfinger Berger, and HSG Zander. The consortium is charged with the construction and operation of the center.

The contract between the bidding consortium and the UK S-H covers planning, construction, financing as well as technical operation including maintenance for the particle therapy system in a public-private partnership over a period of 25 years.